TABLE 2.

Differences in biomarkers among study groups.

	Controls (n = 61)	Febrile seizures (n = 78)	Epileptic seizures (n = 16)
sNfL, pg/ml	23.4 (19.2–27.4)	21.7 (19.6–23.9)	17.7 (13.8–21.6)
Prolactin, mU/L	320 (277–362)∗	411 (365–458)∗	429 (266–592)
Copeptin, pmol/L	9.7 (6.4–12.9)†,‡	39.9 (26.1–53.8)†	30 (13.7–46.2)‡

Data are presented as mean (CI). ^∗p = 0.012 for febrile seizures vs controls. ^†p < 0.001 for febrile seizures vs controls. ^‡p = 0.002 for epileptic seizures vs controls. Between-group comparisons were performed with Kruskal–Wallis one-way ANOVA test (with Bonferroni correction for multiple comparisons).